Point of Care Test Technology Suitable for Early Detection and Monitoring of Ischemic Stroke

Young Mi Lee1, Mi Jung Bae1, Ye Seul Choi1

  • 1Department of Physiology, School of Medicine, Kyungpook National University, Daegu 41405,Korea.

Insights

A novel filter system detects soluble P-selectin, a stroke biomarker, using quantum dots for early ischemic stroke diagnosis. This method simplifies analysis and enhances sensitivity for point-of-care testing.

Area of Science:

  • Biomarker detection
  • Nanotechnology applications
  • Point-of-care diagnostics

Background:

  • Stroke is a major cause of adult death and disability globally.
  • Early detection and monitoring of high-risk patients are crucial for stroke management.
  • Soluble P-selectin is a key biomarker for platelet aggregation, elevated in stroke and other cardiovascular diseases.

Purpose of the Study:

  • To develop a simple, sensitive method for detecting elevated soluble P-selectin levels in stroke patients.
  • To enable early diagnosis, hospital monitoring, and risk assessment for ischemic stroke.
  • To create a point-of-care test (POCT) that complements existing diagnostic capabilities.

Main Methods:

  • A three-layered filter system was developed to separate plasma proteins from whole blood.
  • Quantum dots conjugated with antibodies were used to detect soluble P-selectin.
  • Fluorescence spectrophotometry was employed for quantitative measurement of the biomarker.

Main Results:

  • The developed system achieved a lower limit of detection for soluble P-selectin at 10 pg/ul.
  • Saturation signal intensity was observed at 5 ng/ul, indicating the upper detection limit.
  • The method demonstrated high sensitivity and simplified the analytical process.

Conclusions:

  • A novel three-layer filter membrane system combined with quantum dot-labeled antibodies enables sensitive biomarker detection.
  • This approach simplifies blood analysis and holds potential for point-of-care testing in clinical settings.
  • The proposed system aims to improve stroke diagnosis and patient monitoring through accessible technology.
Abstract